At close: Apr 22, 5:00 PM EST
$6.91
0.121.77%
After Hours: 4:01 PM EST
LifeStance Health Group Inc Analyst Ratings
LFSTNASDAQ
LifeStance Health Gr Analyst Ratings and Price Targets | NASDAQ:LFST | Benzinga
LifeStance Health Group Inc has a consensus price target of $9.23 based on the ratings of 13 analysts. The high is $12 issued by UBS on February 26, 2026. The low is $7 issued by Barclays on November 11, 2024. The 3 most-recent analyst ratings were released by Barclays, Canaccord Genuity, and UBS on March 6, 2026, February 26, 2026, and February 26, 2026, respectively. With an average price target of $10.33 between Barclays, Canaccord Genuity, and UBS, there's an implied 49.54% upside for LifeStance Health Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Canaccord Genuity
UBS
Keybanc
BTIG
1calculated from analyst ratings
Analyst Ratings for LifeStance Health Gr
Loading calendar...
FAQ
What is the target price for LifeStance Health Gr (LFST) stock?
The latest price target for LifeStance Health Gr (NASDAQ:LFST) was reported by Barclays on March 6, 2026. The analyst firm set a price target for $9.00 expecting LFST to rise to within 12 months (a possible 30.25% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LifeStance Health Gr (LFST)?
The latest analyst rating for LifeStance Health Gr (NASDAQ:LFST) was provided by Barclays, and LifeStance Health Gr maintained their overweight rating.
When was the last upgrade for LifeStance Health Gr (LFST)?
The last upgrade for LifeStance Health Group Inc happened on May 27, 2025 when UBS raised their price target to $8.5. UBS previously had a neutral for LifeStance Health Group Inc.
When was the last downgrade for LifeStance Health Gr (LFST)?
There is no last downgrade for LifeStance Health Gr.
When is the next analyst rating going to be posted or updated for LifeStance Health Gr (LFST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeStance Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeStance Health Gr was filed on March 6, 2026 so you should expect the next rating to be made available sometime around March 6, 2027.
Is the Analyst Rating LifeStance Health Gr (LFST) correct?
While ratings are subjective and will change, the latest LifeStance Health Gr (LFST) rating was a maintained with a price target of $8.00 to $9.00. The current price LifeStance Health Gr (LFST) is trading at is $6.91, which is out of the analyst’s predicted range.
